Health
Study suggests a new way to personalize anti-CTLA-4 therapy for cancers – News-Medical.Net
A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune…
A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors. The tumors in question are relatively less reliant on burning sugar through a biochemical process known as glycolysis.
Researchers led by Taha Merghoub and Jedd Wolchok of the Ludwig Center at Memorial Sloan Kettering Cancer Center (MSK) and former postdoc Roberta Zappasodi-;now at Weill Cornell…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News17 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor